Press releases & Latest news
Strengthened patent protection for arfolitixorin in Japan
GOTHENBURG, Sweden, September 1, 2020 – Isofol Medical AB (publ), (Nasdaq First North Premier Growth Market: ISOFOL), has announced today…
Invitation to a conference call and webcast by Isofol in connection with the entered license agreement with Solasia
GOTHENBURG, Sweden, August 13, 2020 - Isofol Medical AB (publ) (“Isofol”), (Nasdaq First North Premier Growth Market: ISOFOL) has today…
Isofol enters licensing agreement with Solasia to develop and commercialize arfolitixorin in Japan
GOTHENBURG, Sweden, August 13, 2020 - Isofol Medical AB (publ) (“Isofol”), (Nasdaq First North Premier Growth Market: ISOFOL) today announced…
Upcoming Events
- October 05, 2020 - October 06, 2020
HealthTech Innovation Days, Paris - October 07, 2020 - October 07, 2020
Erik Penser Bank
Isofol will be attending Erik Penser Bank´s event "Cancer research - Frontline". The event is a digital seminar and will be broadcast live. Link will be added closer to the event. - November 13, 2020 - November 13, 2020
Interim Report Q3 2020 - November 26, 2020 - November 26, 2020
RedEye: Life Science Day
Isofol will attending Redeye´s event "Life Science Day" in Stockholm. The seminar will also be broadcast live.